- Acumen Powered by Robins Kaplan LLP®
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 17, 2024Emily Tremblay Named IP Rising Star by Euromoney in 2024 Women in Business Law Awards
-
June 17, 2024Three Robins Kaplan Partners Named BTI Client Service All-Stars
-
June 13, 2024Brendan Johnson Named South Dakota Trial Lawyer of The Year
-
June 27, 2024Sex Abuse Litigation
-
June 10-11, 20242024 Probate and Trust Law Section Conference
-
June 11, 2024FBA 2024 Federal Practice Seminar
-
June 2024Robins Kaplan Secures Landmark $7.75 Million Verdict in Aerosol Duster Misuse Case
-
June 2024To Seize or Not to Seize: Campus Protests and Police Uses of Force
-
June 2024Communicating Your Estate Plan: A Helpful Tool, Not a Fix-All
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
$358 Million Settlement in Multidistrict Litigation Against Manufacturer of Benicar
August 2017
Benicar Multi-District Litigation, MDL
In a 2013 Safety Announcement, the FDA warned that the popular blood pressure medication marketed as Benicar, Benicar HCT, Azor, or Tribenzor, can cause severe intestinal problems known as spruce-like enteropathy. Symptoms of spruce-like enteropathy can include chronic diarrhea, weight loss, nausea and vomiting which may become so severe that they require hospitalization, extreme dehydration, kidney failure, and malnourishment. The FDA required that manufacturer Daiichi-Sankyo change its label to provide consumers with a warning of this potential injury.
Robins Kaplan filed dozens of claims against the manufacturer in both Federal and New Jersey State Court and, in April 2015, the federal court cases were consolidated into a multidistrict litigation (MDL) in the District of New York.
Partner Tara Sutton was appointed to the Plaintiff’s Executive Committee and the Chair of the Science Committee. Robins Kaplan mass tort partners were likewise appointed to leadership positions within the MDL. Partner Holly Dolejsi served on the Bellwether Committee of the Benicar (Olmesartan) Multi-District Litigation. Partner Rayna Kessler served as the State/Federal Coordination Chairperson for the Plaintiff Steering Committee. Tara Sutton, along with attorneys from other leadership firms, negotiated a global $358 million settlement.
Related Professionals
Rayna E. Kessler
Partner
Similar Results
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.